|Grant Number:||5R01CA129435-03 Interpret this number|
|Primary Investigator:||Freedman, Matthew|
|Organization:||Dana-Farber Cancer Inst|
|Project Title:||Fine Mapping and Characterization of the 8q24 Prostate Cancer Risk Locus|
DESCRIPTION (provided by applicant): The ultimate objective of this proposal is to understand the genetic elements driving sporadic prostate cancer across multiple ethnic groups. Both somatic and, more recently, inherited genetic data highlight a 490 kilobase (kb) noncoding region on chromosome 8q24 as playing a major role in prostate cancer biology across multiple ethnic populations. At least 7 alleles are associated with prostate cancer risk. This finding represents the first validated genetic factor responsible for an appreciable amount of risk in the general population. Aim 1 intends to identify the actual causal alleles at 8q24 contributing to prostate cancer risk across five racial/ethnic populations. First, full characterization of common genetic variation in this 490 kilobase region will be determined by resequencing a multiethnic panel of 48 individuals. Second, all novel SNPs in this region will be genotyped in the well characterized HapMap samples to create a complete collection of all common genetic variation. Third, any newly discovered variants not adequately captured by our previous studies (as assessed by their correlations in HapMap) will be tested for association with prostate cancer in the MEC populations (2,788 incident prostate cancer cases and 2,613 controls). Aim 2 focuses on the intersection between inherited variation at 8q24 and the somatic phenotypes of gene expression and amplification. A total of 200 fresh frozen prostate tumor tissues will be analyzed (150 European American men and 50 African American men) for both projects. All of these samples will be genotyped for the known inherited risk alleles as well as any that are discovered during the course of this project. Since the risk alleles are noncoding, one hypothesis is that they are elevating risk by modulating expression levels of a gene in the vicinity. The expression study will take place in two stages. First, a comprehensive expression analysis covering 3.8 megabases of the 8q24 region will be assessed by tiling arrays to capture both annotated and unannotated transcribed sequences. Forty men representing the extremes of the risk allele distribution will be selected for this stage. Second, any candidate differentially expressed sequence will be validated in an independent sample of 160 men. Having identified a germline risk variant provides the unique opportunity to explore connections between the germline and somatic genomes. Amplification of the 8q region is one of the most frequent somatic lesions in prostate cancer. Tumors are often described as undergoing an evolutionary process of selection for tumor related traits. A new method based on this framework will be applied to evaluate if the risk allele resides on an amplified 8q chromosome more often than expected by chance. This observation would provide compelling evidence that the risk allele is selected for and, therefore, critical for tumor evolution. RELEVANCE TO PUBLIC HEALTH: Identifying the genetic factors underlying prostate cancer provides the opportunity to identify individuals at risk of developing disease as well as to lend insight into pathways that can be modulated for therapeutic benefit. Our proposal aims to pinpoint the causal changes in DNA sequence and the gene that it influences to better understand how this chromosomal region is responsible for an appreciable fraction of prostate cancer in the general population.
Evaluation Of The 8q24 Prostate Cancer Risk Locus And Myc Expression
Authors: Pomerantz M.M. , Beckwith C.A. , Regan M.M. , Wyman S.K. , Petrovics G. , Chen Y. , Hawksworth D.J. , Schumacher F.R. , Mucci L. , Penney K.L. , et al. .
Source: Cancer Research, 2009-07-01 00:00:00.0; 69(13), p. 5568-74.
The 8q24 Cancer Risk Variant Rs6983267 Shows Long-range Interaction With Myc In Colorectal Cancer
Authors: Pomerantz M.M. , Ahmadiyeh N. , Jia L. , Herman P. , Verzi M.P. , Doddapaneni H. , Beckwith C.A. , Chan J.A. , Hills A. , Davis M. , et al. .
Source: Nature Genetics, 2009 Aug; 41(8), p. 882-4.
Functional Enhancers At The Gene-poor 8q24 Cancer-linked Locus
Authors: Jia L. , Landan G. , Pomerantz M. , Jaschek R. , Herman P. , Reich D. , Yan C. , Khalid O. , Kantoff P. , Oh W. , et al. .
Source: Plos Genetics, 2009 Aug; 5(8), p. e1000597.
A Systematic Approach To Understand The Functional Consequences Of Non-protein Coding Risk Regions
Authors: Coetzee G.A. , Jia L. , Frenkel B. , Henderson B.E. , Tanay A. , Haiman C.A. , Freedman M.L. .
Source: Cell Cycle (georgetown, Tex.), 2010-01-15 00:00:00.0; 9(2), p. 256-9.
Exploring Genetic Susceptibility To Cancer In Diverse Populations
Authors: Haiman C.A. , Stram D.O. .
Source: Current Opinion In Genetics & Development, 2010 Jun; 20(3), p. 330-5.
8q24 Prostate, Breast, And Colon Cancer Risk Loci Show Tissue-specific Long-range Interaction With Myc
Authors: Ahmadiyeh N. , Pomerantz M.M. , Grisanzio C. , Herman P. , Jia L. , Almendro V. , He H.H. , Brown M. , Liu X.S. , Davis M. , et al. .
Source: Proceedings Of The National Academy Of Sciences Of The United States Of America, 2010-05-25 00:00:00.0; 107(21), p. 9742-6.
Genome-wide Association Study Of Prostate Cancer Mortality
Authors: Penney K.L. , Pyne S. , Schumacher F.R. , Sinnott J.A. , Mucci L.A. , Kraft P.L. , Ma J. , Oh W.K. , Kurth T. , Kantoff P.W. , et al. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2010 Nov; 19(11), p. 2869-76.
Analysis Of The 10q11 Cancer Risk Locus Implicates Msmb And Ncoa4 In Human Prostate Tumorigenesis
Authors: Pomerantz M.M. , Shrestha Y. , Flavin R.J. , Regan M.M. , Penney K.L. , Mucci L.A. , Stampfer M.J. , Hunter D.J. , Chanock S.J. , Schafer E.J. , et al. .
Source: Plos Genetics, 2010 Nov; 6(11), p. e1001204.
Association Of Prostate Cancer Risk Loci With Disease Aggressiveness And Prostate Cancer-specific Mortality
Authors: Pomerantz M.M. , Werner L. , Xie W. , Regan M.M. , Lee G.S. , Sun T. , Evan C. , Petrozziello G. , Nakabayashi M. , Oh W.K. , et al. .
Source: Cancer Prevention Research (philadelphia, Pa.), 2011 May; 4(5), p. 719-28.
Chromosome 8q24-associated Cancers And Myc
Authors: Grisanzio C. , Freedman M.L. .
Source: Genes & Cancer, 2010 Jun; 1(6), p. 555-9.
The Genetics Of Cancer Risk
Authors: Pomerantz M.M. , Freedman M.L. .
Source: Cancer Journal (sudbury, Mass.), 2011 Nov-Dec; 17(6), p. 416-22.
Cost-effective, High-throughput Dna Sequencing Libraries For Multiplexed Target Capture
Authors: Rohland N. , Reich D. .
Source: Genome Research, 2012 May; 22(5), p. 939-46.
Genetic And Functional Analyses Implicate The Nudt11, Hnf1b, And Slc22a3 Genes In Prostate Cancer Pathogenesis
Authors: Grisanzio C. , Werner L. , Takeda D. , Awoyemi B.C. , Pomerantz M.M. , Yamada H. , Sooriakumaran P. , Robinson B.D. , Leung R. , Schinzel A.C. , et al. .
Source: Proceedings Of The National Academy Of Sciences Of The United States Of America, 2012-07-10 00:00:00.0; 109(28), p. 11252-7.
Integrative Eqtl-based Analyses Reveal The Biology Of Breast Cancer Risk Loci
Authors: Li Q. , Seo J.H. , Stranger B. , McKenna A. , Pe'er I. , Laframboise T. , Brown M. , Tyekucheva S. , Freedman M.L. .
Source: Cell, 2013-01-31 00:00:00.0; 152(3), p. 633-41.
Integrative Clinical Genomics Of Advanced Prostate Cancer
Authors: Robinson D. , Van Allen E.M. , Wu Y.M. , Schultz N. , Lonigro R.J. , Mosquera J.M. , Montgomery B. , Taplin M.E. , Pritchard C.C. , Attard G. , et al. .
Source: Cell, 2015-05-21 00:00:00.0; 161(5), p. 1215-28.
Causel: An Epigenome- And Genome-editing Pipeline For Establishing Function Of Noncoding Gwas Variants
Authors: Spisák S. , Lawrenson K. , Fu Y. , Csabai I. , Cottman R.T. , Seo J.H. , Haiman C. , Han Y. , Lenci R. , Li Q. , et al. .
Source: Nature Medicine, 2015 Nov; 21(11), p. 1357-63.